Actively Recruiting

Phase Not Applicable
Age: 3Years - 50Years
All Genders
NCT07010445

MiCrobiota-gut-brain Axis in Resistant Epilepsy

Led by Niguarda Hospital · Updated on 2026-04-09

120

Participants Needed

1

Research Sites

128 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Epilepsy is one of the most common neurological chronic conditions with a serious burden on patients, their caregivers, and society. Drug-resistant epilepsy (DRE) heightens this burden. New approaches are thus a priority. Studies in animal models and humans have shown the link between gut microbiota (GM) and the central nervous system in health, neurological conditions, and neurodevelopmental disorders. DRE has been linked to GM dysbiosis. Preliminary findings in children with DRE showed GM modifications when responding to a ketogenic diet. The mediator role of GM has not yet been studied in DRE patients undergoing surgery/vagal nerve stimulation. CARE's central hypothesis is that the GM and its metabolic profile could contribute to clinical outcomes following these different therapeutic procedures. Identifying microbial biomarkers will enable us to deepen the knowledge of the role of gut-brain axis in epilepsy and to tailor the intervention to each patient based on GM modulation.

CONDITIONS

Official Title

MiCrobiota-gut-brain Axis in Resistant Epilepsy

Who Can Participate

Age: 3Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 3 and 50 years
  • Diagnosis of epilepsy at onset or drug-resistant epilepsy
  • Ability to participate with or without a caregiver
  • Willingness to sign the informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of organic gastrointestinal disorders such as chronic inflammatory bowel disease
  • Following special diets
  • Use of antibiotics, corticoids, or probiotics within the previous month

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

ASST GOM Niguarda

Milan, Lombardy, Italy, 20162

Actively Recruiting

Loading map...

Research Team

A

Aglaia Vignoli, Prof, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here